Patrick Brossard
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Emapalumab in Patients With Macrophage Activation Syndrome Associated With Still's Disease: A Population Pharmacokinetic/Pharmacodynamic Analysis.
Journal: Clinical and translational science
Published: November 13, 2024
Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
Journal: Rheumatology and therapy
Published: February 01, 2024
Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations.
Journal: BMC veterinary research
Published: March 06, 2018
Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis.
Journal: European journal of drug metabolism and pharmacokinetics
Published: March 12, 2017
Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers.
Journal: Regulatory toxicology and pharmacology : RTP
Published: December 20, 2016
Validation of an emergency triage scale for obstetrics and gynaecology: a prospective study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: December 20, 2016
Evaluation of Nicotine Pharmacokinetics and Subjective Effects following Use of a Novel Nicotine Delivery System.
Journal: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Published: November 21, 2016
Differential effects of ponesimod, a selective S1P1 receptor modulator, on blood-circulating human T cell subpopulations.
Journal: Immunopharmacology and immunotoxicology
Published: December 19, 2014
Three different up-titration regimens of ponesimod, an S1P1 receptor modulator, in healthy subjects.
Three different up-titration regimens of ponesimod, an S1P1 receptor modulator, in healthy subjects.
Journal: Journal of clinical pharmacology
Published: October 14, 2014
Effects of ethnicity and sex on the pharmacokinetics and pharmacodynamics of the selective sphingosine-1-phosphate receptor 1 modulator ponesimod: a clinical study in Japanese and Caucasian subjects.
Journal: Pharmacology
Published: September 22, 2014
Mass balance, pharmacokinetics and metabolism of the selective S1P1 receptor modulator ponesimod in humans.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: September 05, 2014
Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.
Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.
Journal: Basic & clinical pharmacology & toxicology
Published: July 28, 2014
Last Updated: 09/26/2026